EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SARS-CoV-2 spike protein expression drives post-acute coagulopathy

Chih-Feng Tien, En-Ju Lin, Wei-Hsiang Tsai, Wan-Ting Tsai, Ming-Yu Chen, Yu-Siang Su, Han-Chieh Wu, Yueh-Tzu Chiu, Wan-Ju Tung iD, Yi-Ping Kuo, Yu-Wen Su, Hsin-Wei Chen und 4 weitere

Journal of Virology · 2026

DOI: 10.1128/jvi.01255-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2026. Verfasst von Chih-Feng Tien und 15 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, COVID-19, SARS-CoV-2, Blood Coagulation Disorders. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health Research Institutes, National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

During the COVID-19 pandemic, multiple SARS-CoV-2 variants emerged, each with distinct pathogenicity and transmissibility. This study investigated the role of the viral spike (S) protein in disease progression, focusing on the highly virulent S variant. The Delta S protein exhibited enhanced cleavage efficiency at the S1/S2 junction, resulting in partial dissociation of the S1 subunit, with detectable levels of extracellular S1. Unexpectedly, transient expression of Ancestral and Delta S protein induced by a recombinant vesicular stomatitis viral vector caused mild pulmonary inflammation, neutrophil activation, microthrombosis, and ~40% mortality in transgenic K18-hACE2 mice between 8 and 16 days, similar to post-COVID sequelae. The diseased mice displayed splenic atrophy and systemic inflammation, with elevated serum IGFBP-1 and CXCL13 levels. Consistent with the animal findings, serum samples from long COVID patients showed significantly elevated IGFBP-1 levels. CXCL13 levels were particularly elevated in patients with more severe long COVID symptoms. Notably, treatment with the antiplatelet agent aspirin significantly reduced both mortality and weight loss in mice exposed to Delta S protein expression. These findings suggest that SARS-CoV-2 S protein-associated coagulation and systemic inflammation during infection may contribute to the development of post-acute sequelae of COVID-19. IMPORTANCE Our study investigates the distinctive pathogenic properties of the SARS-CoV-2 spike (S) protein from highly virulent variants, with a particular focus on its delayed pathological effects in mice. Using a vesicular stomatitis virus (VSV) vector to transiently express the Ancestral and Delta variant S proteins in K18-hACE2 mice, we observed minimal acute symptoms initially; however, approximately 40% of the mice developed mild pulmonary inflammation, neutrophil activation, and microthrombosis, leading to death between 8 and 16 days post-infection. This delayed pathology was accompanied by elevated circulating levels of CXCL13 and IGFBP-1. Consistent with these findings, serum samples from long COVID patients also showed significantly increased IGFBP-1 levels, while CXCL13 levels were particularly elevated in individuals with more severe long COVID symptoms. These findings provide important observational evidence that may guide future mechanistic studies on long COVID and inform the development of potential therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusCOVID-19SARS-CoV-2Blood Coagulation DisordersAnimalsMicePost-Acute COVID-19 SyndromeHumansMice, TransgenicChemokine CXCL13Insulin-Like Growth Factor Binding Protein 1FemaleMaleDisease Models, Animal

Stichwörter der Autor:innen

CXCL13DeltaIGFBP-1OmicronPASCS1 subunitSARS-CoV-2VSVfibrinogenlong COVIDmicrocoagulationorgan dysfunctionspike

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Chemokine CXCL13Insulin-Like Growth Factor Binding Protein 1

Autor:innen und Institutionen

  • National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan, Taiwan.
  • Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
  • Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Pharmacology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

ORCID-Profile: Wan-Ju Tung, Guann-Yi Yu

Förderung

  • National Health Research Institutes
  • National Science and Technology Council

Zitieren

APA

Tien, C. F., Lin, E. J., Tsai, W. H., Tsai, W. T., Chen, M. Y., Su, Y. S., Wu, H. C., Chiu, Y. T., Tung, W. J., Kuo, Y. P., Su, Y. W., Chen, H. W., Chen, F. J., Chuang, T. H., Wang, H. T., & Yu, G. Y. (2026). SARS-CoV-2 spike protein expression drives post-acute coagulopathy. Journal of Virology. https://doi.org/10.1128/jvi.01255-25

Vancouver

Tien CF, Lin EJ, Tsai WH, Tsai WT, Chen MY, Su YS, et al. SARS-CoV-2 spike protein expression drives post-acute coagulopathy. Journal of Virology. 2026. doi:10.1128/jvi.01255-25

BibTeX
@article{Tien2026,
  author = {Tien, Chih-Feng and Lin, En-Ju and Tsai, Wei-Hsiang and Tsai, Wan-Ting and Chen, Ming-Yu and Su, Yu-Siang and Wu, Han-Chieh and Chiu, Yueh-Tzu and Tung, Wan-Ju and Kuo, Yi-Ping and Su, Yu-Wen and Chen, Hsin-Wei and Chen, Feng-Jui and Chuang, Tsung-Hsien and Wang, Hsiang-Tsui and Yu, Guann-Yi},
  title = {SARS-CoV-2 spike protein expression drives post-acute coagulopathy},
  journal = {Journal of Virology},
  year = {2026},
  doi = {10.1128/jvi.01255-25}
}
Kostenlos starten →